ArticleBlood2018

Pan-SRC kinase inhibition blocks B-cell receptor oncogenic signaling in non-Hodgkin lymphoma.

Elena Battistello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.